Brief: Alx Oncology Reports Inducement Grant As Permitted By The Nasdaq Listing Rules
17/04/2026 21:36
April 17 (Reuters) - ALX Oncology Holdings Inc ALXO.O: ALX ONCOLOGY REPORTS INDUCEMENT GRANT AS PERMITTED BY THE NASDAQ LISTING RULES Source text: ID:nGNX34lYhG Further company coverage: ALXO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ALX Oncology Holdings
See all newsALX Oncologys' Q1 loss narrows on lower expenses
Brief: ALX Oncology Q1 Basic EPS USD -0.17
Brief: Alx Oncology’S Evorpacept In Combination With Zanidatamab Generates Promising, Durable Response In Patients With Advanced Her2-Positive Breast Cancer And High Cd47 Expression
Brief: Alx Oncology Reports Inducement Grant As Permitted By The Nasdaq Listing Rules
ALX Oncology Q4 loss narrows, names permanent CMO